Places and Things

UC Berkeley loses CRISPR patent case If you buy something from a Verge link, Vox Media may earn a commission. See our ethics statement. MIT and Harvard’s Broad Institute was the first to apply the gene-editing tool CRISPR to human cells, the US Patent and Trademark Office said Monday. Continue Reading . . . https://www.theverge.com/2022/3/1/22956326/crispr-patent-uc-berkeley-broad-institute-nobel

CRISPR gene editing breakthrough could treat many more diseases CRISPR gene editing already promises to fight diseases that were once thought unassailable, but techniques so far have required injecting the tools directly into affected cells. That's not very practical for some conditions. However, there's just been a breakthrough. Continue Reading . . . https://www.engadget.com/crispr-gene-editing-blood-injection-213815705.html